IL-15 Is Highly Expressed in Inflammatory Bowel Disease and Regulates Local T Cell-Dependent Cytokine Production1

IL-15 shares biological activities but no significant sequence homology with IL-2. It induces T cell recruitment to sites of inflammation, T cell proliferation, and cytokine production and rescue from apoptosis. The aim of this study was to investigate expression of IL-15 and its effects on proinflammatory cytokine production in inflammatory bowel disease (IBD). Immunohistochemistry demonstrated local IL-15 production by macrophages in inflamed mucosa from IBD patients. Isolated lamina propria mononuclear cells from these patients but not from controls produced IL-15 when stimulated with LPS or IFN-γ. Moreover, lamina propria T cells (LP-T) from IBD patients were more responsive to IL-15 as compared with controls, and IL-15 alone without a primary T cell stimulus induced IFN-γ and TNF production by isolated IBD LP-T cells, especially by LP-T cells from patients with Crohn’s disease. LP-T cells from IBD patients could induce CD40-CD40 ligand (CD40L) interaction-dependent TNF and IL-12 production by monocytes in a coculture system. This capacity of LP-T cells was strongly enhanced by preincubation in IL-15 and was the result of higher CD40L expression after culture in IL-15. These data indicate that IL-15 is overexpressed in the inflamed mucosa in IBD and that IL-15 enhances local T cell activation, proliferation, and proinflammatory cytokine production by both T cells and macrophages, the latter via a CD40-CD40L interaction-dependent mechanism. Treatment directed against IL-15 may have therapeutic potential in IBD.

[1]  M. Zeitz,et al.  T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. , 1992, Journal of immunology.

[2]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, The EMBO journal.

[3]  M. Caligiuri,et al.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor , 1994, The Journal of experimental medicine.

[4]  V. Fung,et al.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.

[5]  R. Testi,et al.  The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. , 1994, Immunology today.

[6]  R. Rees,et al.  Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Giri.  Identification and cloning of a nobel IL - 15 binding protein that is strucurally related to the αchain of the IL - 2 receptor. , 1995 .

[8]  M. Caligiuri,et al.  Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. , 1995, The Journal of clinical investigation.

[9]  F. Liew,et al.  Chemoattraction of human blood T lymphocytes by interleukin-15 , 1995, The Journal of experimental medicine.

[10]  R. Dubose,et al.  Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.

[11]  R. Paxton,et al.  IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. , 1995, Journal of immunology.

[12]  J Bajorath,et al.  Immune regulation by CD40 and its ligand GP39. , 1996, Annual review of immunology.

[13]  A. Sher,et al.  Induction and regulation of IL-15 expression in murine macrophages. , 1996, Journal of immunology.

[14]  R. Seder.  High-dose IL-2 and IL-15 enhance the in vitro priming of naive CD4+ T cells for IFN-gamma but have differential effects on priming for IL-4. , 1996, Journal of immunology.

[15]  I. McInnes,et al.  The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis , 1996, Nature Medicine.

[16]  O. Kaminuma,et al.  IL-15 promotes cytokine production of human T helper cells. , 1996, Journal of immunology.

[17]  N. Boiani,et al.  Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: involvement in interleukin‐2‐induced interleukin‐12 and interferon‐γ production , 1996, European journal of immunology.

[18]  H. Kanegane,et al.  Activation of naive and memory T cells by interleukin-15. , 1996, Blood.

[19]  T. Waldmann,et al.  IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. , 1996, Immunity.

[20]  O. Nielsen,et al.  Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. , 1996, The American journal of gastroenterology.

[21]  R. Zambello,et al.  Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. , 1996, Journal of immunology.

[22]  I. McInnes,et al.  Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis , 1997, Nature Medicine.

[23]  A. Enk,et al.  Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T cells. , 1997, Journal of immunology.

[24]  T. Strom,et al.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Paus,et al.  Interleukin-15 protects from lethal apoptosis in vivo , 1997, Nature Medicine.

[26]  S. Targan,et al.  A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .

[27]  N. D. Mar,et al.  IL-15, an immunomodulator of T cell responses in intracellular infection. , 1997, Journal of immunology.

[28]  E. Ebert.  Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. , 1998, Gastroenterology.

[29]  R. Flavell,et al.  CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.

[30]  M. Armant,et al.  IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation. , 1998, Journal of immunology.

[31]  P. Nickerson,et al.  IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. , 1998, Journal of immunology.

[32]  Y. Yoshikai,et al.  Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. , 1998, Gastroenterology.

[33]  F. Pallone,et al.  Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 , 1998, Gut.

[34]  Y. S. Kim,et al.  Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. , 1998, Journal of immunology.

[35]  R. Brezinschek,et al.  Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. , 1998, The Journal of clinical investigation.

[36]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[37]  I. McInnes,et al.  Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. , 1998, Journal of immunology.

[38]  S. Targan,et al.  Current theories on the causes of inflammatory bowel disease. , 1999, Gastroenterology clinics of North America.

[39]  P. Rutgeerts,et al.  Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. , 1999, Journal of immunology.

[40]  D. Jarrossay,et al.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.

[41]  D. Carr,et al.  Regulation of IL-15-Stimulated TNF-a Production by Rolipram 1 , 1999 .

[42]  D. Carr,et al.  Regulation of IL-15-Stimulated TNF-α Production by Rolipram , 1999, The Journal of Immunology.

[43]  Clerici,et al.  The Effects of CD40 Ligation on Peripheral Blood Mononuclear Cell Interleukin‐12 and Interleukin‐15 Production and on Monocyte CD14 Surface Antigen Expression in Human Immunodeficiency Virus‐Positive Patients , 1999, Scandinavian journal of immunology.